Oncotarget

Research Papers:

Epstein-Barr virus mir-bart1-5p detection via nasopharyngeal brush sampling is effective for diagnosing nasopharyngeal carcinoma

Xiao-Hui Zheng, Li-Xia Lu, Cui Cui, Ming-Yuan Chen, Xi-Zhao Li and Wei-Hua Jia _

PDF  |  HTML  |  Supplementary Files  |  How to cite  |  Order a Reprint

Oncotarget. 2016; 7:4972-4980. https://doi.org/10.18632/oncotarget.6649

Metrics: PDF 1336 views  |   HTML 1850 views  |   ?  


Abstract

Xiao-Hui Zheng1,2,*, Li-Xia Lu1,*, Cui Cui1,2,*, Ming-Yuan Chen1, Xi-Zhao Li1,2, and Wei-Hua Jia1,2

1Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou 510060, China

2Department of Experimental Research, Sun Yat-Sen University Cancer Center, Guangzhou 510060, China

*These authors have contributed equally to this work

Correspondence to:

Wei-Hua Jia, e-mail: jiawh@sysucc.org.cn

Keywords: nasopharyngeal carcinoma, Epstein-Barr virus, microRNA, nasopharyngeal brush, biomarker

Received: June 02, 2015    Accepted: December 02, 2015    Published: December 18, 2015

ABSTRACT

Epstein-Barr virus (EBV)-encoded microRNAs (miRNAs) are highly expressed in nasopharyngeal carcinoma (NPC) cases in high-risk areas, and may be involved in tumorigenesis. Using quantitative RT-PCR, we detected four EBV-encoded BamHI A rightward transcript (BART) miRNAs (mir-bart1-5p, mir-bart5, mir-bart6-5p and mir-bart17-5p) exclusively in 53 NPC biopsies as compared to 69 controls. In a larger patient group, that included 215 NPC cases and 209 controls, significantly higher levels of all four EBV miRNAs were detected in tumor cells harvested directly from the nasopharynx using a less invasive nasopharyngeal (NP) brush than in the controls (p < 0.001). One EBV miRNA, mir-bart1-5p, holds particular promise for use as a diagnostic indicator of NPC (with 93.5% sensitivity and 100% specificity), and its relative expression level was reflective of disease progression. Detection of this miRNA was effective for diagnosing early-stage NPC, even in cases that were falsely diagnosed as negative based on histopathological analysis, plasma EBV DNA load, and VCA-IgA and EA-IgA titers. EBV-encoded mir-bart1-5p detection via NP brush sampling could act as an efficient and less invasive method assisting clinical diagnosis of NPC.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 6649